Aim: The aim of this study was to develop a high-throughput urine screening technique for adenylosuccinate lyase (ADSL) deficiency and to evaluate S-adenosyl-l-methionine (SAMe) as a potential treatment for this disorder.
Method: Testing for succinyladenosine (S-Ado), a marker of ADSL deficiency, was incorporated into a screening panel for urine biomarkers for inborn errors of metabolism using electrospray tandem mass spectrometry. Liquid chromatography-mass spectrometry and high-performance liquid chromatography were used to confirm and monitor the response of metabolites to oral SAMe treatment.
Results: Increased levels of S-Ado were detected in a 3-month-old male infant with hypotonia and seizures. ADSL gene sequencing revealed a previously described c.-49T>C mutation and a novel c.889_891dupAAT mutation, which was likely to disrupt enzyme function. After 9 months of SAMe treatment, there was no clear response evidenced in urine metabolite levels or clinical parameters.
Interpretation: These results demonstrate proof of the principle for the high-throughput urine screening technique, allowing earlier diagnosis of patients with ADSL deficiency. However, early treatment with SAMe does not appear to be effective in ADSL deficiency. It is suggested that although SAMe treatment may ameliorate purine nucleotide deficiency, it cannot correct metabolic syndromes in which a toxic nucleotide is present, in this case presumed to be succinylaminoimidazole carboxamide ribotide.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/dmcn.12244 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Electroclinical features and phenotypic differences in adenylosuccinate lyase deficiency: Long-term follow-up of seven patients from four families and appraisal of the literature.
Epilepsia Open
February 2024
Department of Pediatric Neurology, Pediatric Neurology Unit, Buzzi Children's Hospital, Milan, Italy.
Article Synopsis
- Adenylosuccinate lyase (ADSL) deficiency is a rare inherited metabolic disorder categorized into three types, with the study focusing on the clinical and electroclinical characteristics of patients.
- Seven previously unreported patients were followed for 10 to 34 years, and a literature review compiled 81 cases, revealing that the majority of patients experience type I deficiency, with epilepsy being a common symptom.
- EEG findings showed distinctive patterns like poor background organization and specific seizure types, while imaging consistently indicated cerebral and cerebellar atrophy, highlighting the need for better understanding and management of this disorder.
Adenylosuccinate lyase deficiency affects neurobehavior via perturbations to tyramine signaling in Caenorhabditis elegans.
PLoS Genet
September 2023
Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
Adenylosuccinate lyase deficiency is an ultrarare congenital metabolic disorder associated with muscle weakness and neurobehavioral dysfunction. Adenylosuccinate lyase is required for de novo purine biosynthesis, acting twice in the pathway at non-sequential steps. Genetic models can contribute to our understanding of the etiology of disease phenotypes and pave the way for development of therapeutic treatments.
View Article and Find Full Text PDFA Caenorhabditis elegans model of adenylosuccinate lyase deficiency reveals neuromuscular and reproductive phenotypes of distinct etiology.
Mol Genet Metab
November 2023
Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA. Electronic address:
Inborn errors of purine metabolism are rare syndromes with an array of complex phenotypes in humans. One such disorder, adenylosuccinate lyase deficiency (ASLD), is caused by a decrease in the activity of the bi-functional purine biosynthetic enzyme adenylosuccinate lyase (ADSL). Mutations in human ADSL cause epilepsy, muscle ataxia, and autistic-like symptoms.
View Article and Find Full Text PDFChild with adenylosuccinate lyase deficiency caused by a novel complex heterozygous mutation in the gene: A case report.
World J Clin Cases
October 2022
Department of Neurology, Affiliated Hospital of Jining Medical University, Jining 272000, Shandong Province, China.
Background: Adenylosuccinate lyase (ADSL) deficiency is a rare autosomal-recessive defect of purine metabolism caused by mutation of the gene. It can cause severe neurological impairment and diverse clinical manifestations, including epilepsy.
Case Summary: Here, we describe a 3-year-old Chinese boy who had both psychomotor retardation and refractory epilepsy.
Anticipatory banking of samples enables diagnosis of adenylosuccinase deficiency following molecular autopsy in an infant with vacuolating leukoencephalopathy.
Am J Med Genet A
January 2023
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Adenylosuccinase deficiency is a rare inborn error of metabolism. We present a newborn who died at 52 days of age with clinical features suggestive of severe epileptic encephalopathy and leukodystrophy of unknown cause. Post-mortem examination showed an unusual vacuolar appearance of the brain.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!